Amgen

Amgen, a leading biotechnology company, is collaborating with NVIDIA to leverage generative AI for drug research and development. Amgen will utilize the NVIDIA DGX SuperPOD at its deCODE genetics’ headquarters in Reykjavik, Iceland, to build a human diversity atlas for drug target and biomarker discovery. This strategic partnership aims to accelerate research, enhance diagnostic capabilities,…